|
|
|
|
|
|
2-Hydroxypropyl-β-cyclodextrin
|
Model No.︰ | 122463 |
Brand Name︰ | Seebio |
Country of Origin︰ | China |
Unit Price︰ | US $ 1 / pc |
Minimum Order︰ | 1 pc |
|
|
|
|
|
Hydroxypropyl - β - cyclodextrin molecular structure and physico-chemical properties |
Β - cyclodextrin by seven glucose units constitute each glucose residues of 2 - 3 -, 6 --hydroxy in hydroxypropyl hydrogen atom can be replaced. 2 - hydroxypropyl - β - cyclodextrin mainly 2 --hydroxy hydrogen atoms substituted product. Compared with β - cyclodextrin, its nature has undergone great change.
① appearance: β - cyclodextrin is white crystals, and 2 - hydroxypropyl - β - cyclodextrin as amorphous glass state body, after grinding for the white powder.
② solubility: β - cyclodextrin solubility smaller, at room temperature only 1.8 g / 100 g water, this also limits its application, and compared with β - cyclodextrin, 2 - hydroxypropyl - β - ring paste Solubility very fine, usually at room temperature> 50 g / 100 g of water, so it can not be in the alcohol solution crystallization.
③ Stability: β - cyclodextrin, 2 - HP-β - cyclodextrin molecules without reducing the thermal and light stability, tolerance 80 ℃ and 4500 lx illumination for 10 days, pressing its solution can be sterilized, in alkaline medium stability, strong acid instability, be strong acid decomposition ④ the metabolic pathway in the body: 2 - HP-β - CD is not gastric acid and alpha-amylase hydrolyzed, almost not participate in the body metabolism, not cumulative. After oral administration to complete all basically in the form of feces excreted, non-intestinal administration basically in the form of integrity with urine excretion. ⑤ toxicity and hemolytic: β - CD renal toxicity, hemolytic and irritating, it is not possible for non-intestinal administration, and 2 - HP-β - CD no renal toxicity, but also because of surfactant low, the role of hemolytic and irritating. ⑥ the complex and the drug release: As chemical structure changes, 2 - HP-β - cyclodextrin and β - CD on the same drug complexation capacity and the main object will be different molecular ratio of β - cyclodextrin in the body of complexation of sustained-release drugs, and the 2 - HP-β - CD release on the role of promoting drugs, biological drugs in the body can prompt release. | Product: | 2-Hydroxypropyl-β-cyclodextrinHP-β-CD | Grade | EP5 Grade | Lot: | OH2302A | Code: | 122463 | CAS-No: | [94035-02-6] | Mol. Formula: | (C42H70-nO35) (C3H7O) n | Mol. Weight: | ~1046.0 | Packing: | 20 Kg / Drum |
Purity | >98.0% | Solubility | >75.0g/100mll | Identification A B | Complies with the tests | Specific rotation | +128.0~+145.0° | Acidity & AIKalinity pH | 5.0~8.0 | Loss on drying | <5.0% | Residue on ignited | <0.5% | Related substances | Impurity A – NMT 1.5% Impurity B – NMT 2.5 % Other impurities – NMT 0.1% Total of other impurities – 1.0% max | Chloride | <0.018% | Heavy metal(Pb) | ≤20ppm | Arsenic | <4ppm | Conductivity | ≤200 uS·cm-1 | Molar substitution | 0.4-1.5 | Microbial contamination | | Bacteria | ≤100 cfu/g | Fungi | ≤100 cfu/g | Escherichia coli | None detected | Salmonella | None detected | Bacterial endotoxins | ≤10 IU/g | Appearance of solution | Clear and colourless | Appearance | White powder |
|
|
|
|
Product Image
|
|
Related Products
|
|
|
|
|
|
|